Observational Study on Risk Factors, Complications, and Management of Polycystic Ovarian Syndrome
January 2018
in “
Deleted Journal
”
New to Metformin? There is a guide in the encyclopedia. Read the guide →
Studysummary In this observational study of 110 women with PCOS, the researchers found that 52.7% experienced depression and anxiety, with Metformin being the most prescribed drug. Regular counseling and lifestyle management were noted to improve the overall disease prognosis.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
In a 2018 prospective observational study involving 110 women with polycystic ovarian syndrome (PCOS) aged 16-38, researchers found that the condition was most prevalent in the 20-30 age group (80.9%). The study, which lasted 6 months, revealed that primary infertility was more common (69.1%) than secondary infertility (31.9%), and a significant number of participants were overweight (34.5%) or obese (17.2%). A high incidence of hirsutism (66.4%), acne (59.1%), hair loss (88.2%), and acanthosis nigricans (72.7%) was observed, along with a notable presence of depression (52.7%) and anxiety (52.7%) among the women. Metformin was the most frequently prescribed medication (45.5%), and a high rate of medication compliance (87.27%) was associated with improved symptom management. The study concluded that addressing the psychological well-being of PCOS patients through education, regular counseling, lifestyle management, and pharmacological therapy is crucial for improving disease prognosis.